Eltrombopag-Induced Serum Pigmentation in Severe Aplastic Anemia: A Case Report
Eva Desbrousses, Tifenn Charbonnel, Flavie Arbion, Hugo Alarcan, Nicolas Vallet · 2026
Read Eltrombopag-Induced Serum Pigmentation in Severe Aplastic Anemia: A Case Report by Eva Desbrousses, Tifenn Charbonnel, Flavie Arbion, Hugo Alarcan, Nicolas Vallet (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13585414.txt.
Description
Eva Desbrousses and colleagues report a striking lab curiosity in a young patient with severe aplastic anemia in this 2026 case paper. Aplastic anemia is a bone marrow failure that leaves the blood short of all cell types. Their patient, a 19-year-old woman, was treated with immune-damping drugs plus eltrombopag, a drug that pushes marrow to make more cells.
Blood samples sent to the lab kept arriving with brown serum after spinning, a rare sight that raised fears of blood breakdown inside the vessels. Tests ruled that danger out, with only a mild rise in one pigment measure. Once the drug was stopped, the brown color faded away. The authors explain that eltrombopag itself absorbs visible light, and they flag the effect so labs do not chase a false alarm.
Catalog record
| CREATOR | Eva Desbrousses, Tifenn Charbonnel, Flavie Arbion, Hugo Alarcan, Nicolas Vallet |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |